Researchers have directly isolated human central nervous system stem cells (hCNS-SC) from human fetal brain tissue using antibodies and fluorescence-activated cell sorting. These cells, identified by markers such as CD133 and 5E12, can self-renew and differentiate into neurons and glial cells. When transplanted into immunodeficient mice, they engraft, proliferate, and differentiate into neural cells. The study shows that hCNS-SC can be enriched and isolated using specific surface markers, and they demonstrate self-renewal and multilineage differentiation potential. The cells were able to reestablish neurosphere cultures and showed engraftment in various brain regions, including the subventricular zone, dentate gyrus, and olfactory bulb. The study also highlights the potential of hCNS-SC for future research on neural development and regeneration. The findings suggest that these cells could be used in preclinical models to study human disease and test their therapeutic potential. The study provides a method for isolating and characterizing human CNS stem cells, which could lead to new treatments for neurological disorders.Researchers have directly isolated human central nervous system stem cells (hCNS-SC) from human fetal brain tissue using antibodies and fluorescence-activated cell sorting. These cells, identified by markers such as CD133 and 5E12, can self-renew and differentiate into neurons and glial cells. When transplanted into immunodeficient mice, they engraft, proliferate, and differentiate into neural cells. The study shows that hCNS-SC can be enriched and isolated using specific surface markers, and they demonstrate self-renewal and multilineage differentiation potential. The cells were able to reestablish neurosphere cultures and showed engraftment in various brain regions, including the subventricular zone, dentate gyrus, and olfactory bulb. The study also highlights the potential of hCNS-SC for future research on neural development and regeneration. The findings suggest that these cells could be used in preclinical models to study human disease and test their therapeutic potential. The study provides a method for isolating and characterizing human CNS stem cells, which could lead to new treatments for neurological disorders.